imiquimod has been researched along with Diabetes Mellitus, Type 2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 5 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jun, L; Kun, X; Lu, L; Pin, C; Wei, C; Xiangjin, X; Xiaohong, L; Xin, L; Yunjie, Y; Zhenting, Z | 1 |
Chen, P; Li, X; Shao, Z; Xu, X | 1 |
Christman, MA; McKinzie, AH | 1 |
An, Q; Du, G; Hao, Y; Li, W; Lu, Y; Ren, L; Wang, J; Yang, D; Yang, H; Yang, Y; Yu, M; Zhang, S; Zhang, Y | 1 |
Brain, SD; Caton, PW; Evans, EA; Frame, J; Hannen, RF; Kodji, X; Philpott, MP; Rizvi, A; Sayers, SR; Shaikh, M; Xia, Y | 1 |
5 other study(ies) available for imiquimod and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Imiquimod; Interferon Regulatory Factor-3; Mice; Psoriasis | 2022 |
DPP-4 inhibitor linagliptin ameliorates imiquimod-induced psoriasis-like skin alterations in type 2 diabetic mice by inhibiting the MAPK/NF-κB inflammatory pathway.
Topics: Animals; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Hypoglycemic Agents; Imiquimod; Insulin Resistance; Interleukin-23; Linagliptin; Mice; NF-kappa B; Psoriasis; Tumor Necrosis Factor-alpha | 2022 |
Imiquimod-Associated Localized Skin Ulceration in a Patient With Uncontrolled Diabetes.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Diabetes Mellitus, Type 2; Humans; Imiquimod | 2022 |
Design, synthesis and characterization of a novel multicomponent salt of bexarotene with metformin and application in ameliorating psoriasis with T2DM.
Topics: Animals; Bexarotene; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Imiquimod; Metformin; Mice; Psoriasis; Sodium Chloride; Tetrahydronaphthalenes | 2023 |
Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome.
Topics: Animals; Cell Proliferation; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Imiquimod; Inflammation; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Prediabetic State; Psoriasis; Skin | 2020 |